APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Active Pharmaceutical Ingredients (API)

Compare research editions
View pricing & licenses

Selected research

Industry Research

Veterinary Active Pharmaceutical Ingredients (API) Industry Research Report 2026

20 December 2025126 pages

Choose your research edition.

Industry ResearchVeterinary Active Pharmaceutical Ingredients (API) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Active Pharmaceutical Ingredients (API) Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Veterinary Active Pharmaceutical Ingredients (API) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Active Pharmaceutical Ingredients (API) Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Active Pharmaceutical Ingredients (API) Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Active Pharmaceutical Ingredients (API) market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Veterinary Active Pharmaceutical Ingredients (API) is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Veterinary Active Pharmaceutical Ingredients (API) is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Veterinary Active Pharmaceutical Ingredients (API) is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Veterinary Active Pharmaceutical Ingredients (API) include Qilu Pharmaceutical (Inner Mongolia) Co, Ltd, Jiangsu Lingyun Pharmaceutical Co. Ltd, SUANFARMAOfichem Group, Procyon Life Sciences, NGL Fine-Chem Ltd, Menadiona, lndukern Group, LasaSupergenerics Ltd. and Huvepharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Veterinary Active Pharmaceutical Ingredients (API) market in terms of revenue (US$ million) and, where applicable, sales volume (k units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Veterinary Active Pharmaceutical Ingredients (API) Market by Company

Qilu Pharmaceutical (Inner Mongolia) Co, Ltd

Jiangsu Lingyun Pharmaceutical Co. Ltd

SUANFARMAOfichem Group

Procyon Life Sciences

NGL Fine-Chem Ltd

Menadiona

lndukern Group

LasaSupergenerics Ltd.

Huvepharma

Excel Veterinary HealthcareVetpharma(Insud Pharma)

Alivira Animal Health Ltd

Veterinary Active Pharmaceutical Ingredients (API) Segment by Type

Biological API

Chemical Based API

Highly Potent APl(HPAPI)

Veterinary Active Pharmaceutical Ingredients (API) Segment by Application

CDMO

CMO

Veterinary Active Pharmaceutical Ingredients (API) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Active Pharmaceutical Ingredients (API) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Active Pharmaceutical Ingredients (API) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Active Pharmaceutical Ingredients (API).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Veterinary Active Pharmaceutical Ingredients (API) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Veterinary Active Pharmaceutical Ingredients (API) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Veterinary Active Pharmaceutical Ingredients (API) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Veterinary Active Pharmaceutical Ingredients (API) Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (k units) of Manufacturers (2021-2026) Table 7. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Manufacturers (2021-2026) Table 8. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue of Manufacturers (2021-2026) Table 9. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Veterinary Active Pharmaceutical Ingredients (API) Average Price (US$/unit) of Manufacturers (2021-2026) Table 11. Global Veterinary Active Pharmaceutical Ingredients (API) Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Product Type & Application Table 14. Global Veterinary Active Pharmaceutical Ingredients (API) Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Veterinary Active Pharmaceutical Ingredients (API) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information Table 19. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Business Overview Table 20. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 21. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 22. Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments Table 23. Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information Table 24. Jiangsu Lingyun Pharmaceutical Co. Ltd Business Overview Table 25. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 26. Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 27. Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments Table 28. SUANFARMAOfichem Group Company Information Table 29. SUANFARMAOfichem Group Business Overview Table 30. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 31. SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 32. SUANFARMAOfichem Group Recent Developments Table 33. Procyon Life Sciences Company Information Table 34. Procyon Life Sciences Business Overview Table 35. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 36. Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 37. Procyon Life Sciences Recent Developments Table 38. NGL Fine-Chem Ltd Company Information Table 39. NGL Fine-Chem Ltd Business Overview Table 40. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 41. NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 42. NGL Fine-Chem Ltd Recent Developments Table 43. Menadiona Company Information Table 44. Menadiona Business Overview Table 45. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 46. Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 47. Menadiona Recent Developments Table 48. lndukern Group Company Information Table 49. lndukern Group Business Overview Table 50. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 51. lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 52. lndukern Group Recent Developments Table 53. LasaSupergenerics Ltd. Company Information Table 54. LasaSupergenerics Ltd. Business Overview Table 55. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 56. LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 57. LasaSupergenerics Ltd. Recent Developments Table 58. Huvepharma Company Information Table 59. Huvepharma Business Overview Table 60. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 61. Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 62. Huvepharma Recent Developments Table 63. Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information Table 64. Excel Veterinary HealthcareVetpharma(Insud Pharma) Business Overview Table 65. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 66. Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 67. Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments Table 68. Alivira Animal Health Ltd Company Information Table 69. Alivira Animal Health Ltd Business Overview Table 70. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio Table 72. Alivira Animal Health Ltd Recent Developments Table 73. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 74. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2021-2026) & (k units) Table 75. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2021-2026) Table 76. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region (2027-2032) & (k units) Table 77. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Region (2027-2032) Table 78. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2021-2026) & (US$ Million) Table 79. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2021-2026) Table 80. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region (2027-2032) & (US$ Million) Table 81. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Region (2027-2032) Table 82. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 83. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 84. North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 85. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (US$ Million) Table 86. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2027-2032) & (US$ Million) Table 87. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 88. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 89. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 90. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (US$ Million) Table 91. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2027-2032) & (US$ Million) Table 92. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 93. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 94. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 95. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (US$ Million) Table 96. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2027-2032) & (US$ Million) Table 97. South America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 98. South America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 99. South America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 100. South America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (US$ Million) Table 101. South America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2027-2032) & (US$ Million) Table 102. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2026) & (k units) Table 104. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2027-2032) & (k units) Table 105. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2026) & (US$ Million) Table 106. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2027-2032) & (US$ Million) Table 107. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2026) & (k units) Table 108. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2027-2032) & (k units) Table 109. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2026) Table 110. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2027-2032) Table 111. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2026) & (US$ Million) Table 112. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2027-2032) & (US$ Million) Table 113. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2026) Table 114. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2027-2032) Table 115. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2021-2026) & (US$/unit) Table 116. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2027-2032) & (US$/unit) Table 117. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2026) & (k units) Table 118. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2027-2032) & (k units) Table 119. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2026) Table 120. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2027-2032) Table 121. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2026) & (US$ Million) Table 122. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2027-2032) & (US$ Million) Table 123. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2026) Table 124. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2027-2032) Table 125. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2021-2026) & (US$/unit) Table 126. Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2027-2032) & (US$/unit) Table 127. Key Raw Materials Table 128. Raw Materials Key Suppliers Table 129. Veterinary Active Pharmaceutical Ingredients (API) Distributors List Table 130. Veterinary Active Pharmaceutical Ingredients (API) Customers List Table 131. Veterinary Active Pharmaceutical Ingredients (API) Industry Trends Table 132. Veterinary Active Pharmaceutical Ingredients (API) Industry Drivers Table 133. Veterinary Active Pharmaceutical Ingredients (API) Industry Restraints Table 134. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Veterinary Active Pharmaceutical Ingredients (API) Product Image Figure 5. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size (2021-2032) & (US$ Million) Figure 7. Global Veterinary Active Pharmaceutical Ingredients (API) Sales (2021-2032) & (k units) Figure 8. Global Veterinary Active Pharmaceutical Ingredients (API) Average Price (US$/unit) & (2021-2032) Figure 9. Biological API Product Image Figure 10. Chemical Based API Product Image Figure 11. Highly Potent APl(HPAPI) Product Image Figure 12. CDMO Product Image Figure 13. CMO Product Image Figure 14. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Share by Manufacturers in 2025 Figure 15. Global Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Manufacturing Sites & Headquarters Figure 16. Global Top 5 and 10 Veterinary Active Pharmaceutical Ingredients (API) Players Market Share by Revenue in 2025 Figure 17. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 19. Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region in 2025 Figure 20. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region in 2025 Figure 21. North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country in 2025 Figure 22. North America Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 23. North America Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2021-2032) Figure 24. United States Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 25. Canada Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 26. Mexico Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country in 2025 Figure 28. Europe Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 29. Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2021-2032) Figure 30. Germany Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. France Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 32. U.K. Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. Italy Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. Russia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Spain Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Netherlands Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Switzerland Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Sweden Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Poland Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country in 2025 Figure 41. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 42. Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2021-2032) Figure 43. China Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. Japan Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. South Korea Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. India Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. Australia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Taiwan Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Southeast Asia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. South America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country in 2025 Figure 52. South America Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 53. South America Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2021-2032) Figure 54. Brazil Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Chile Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Colombia Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country in 2025 Figure 59. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Country (2021-2032) Figure 60. Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Country (2021-2032) Figure 61. Egypt Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. South Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. Israel Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Türkiye Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. GCC Countries Veterinary Active Pharmaceutical Ingredients (API) Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2032) Figure 67. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2032) Figure 68. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/unit) by Type (2021-2032) Figure 69. Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2032) Figure 70. Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2032) Figure 71. Global Veterinary Active Pharmaceutical Ingredients (API) Price (US$/unit) by Application (2021-2032) Figure 72. Veterinary Active Pharmaceutical Ingredients (API) Value Chain Figure 73. Veterinary Active Pharmaceutical Ingredients (API) Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Veterinary Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges

Scope & coverage.

Types
  • Biological API
  • Chemical Based API
  • Highly Potent APl(HPAPI)
Applications
  • CDMO
  • CMO
Companies covered
  • Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
  • Jiangsu Lingyun Pharmaceutical Co. Ltd
  • SUANFARMAOfichem Group
  • Procyon Life Sciences
  • NGL Fine-Chem Ltd
  • Menadiona
  • lndukern Group
  • LasaSupergenerics Ltd.
  • Huvepharma
  • Excel Veterinary HealthcareVetpharma(Insud Pharma)
  • Alivira Animal Health Ltd

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size (2021-2032)
  4. 2.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales (2021-2032)
  5. 2.2.3 Global Veterinary Active Pharmaceutical Ingredients (API) Market Average Price (2021-2032)
  6. 2.3 Veterinary Active Pharmaceutical Ingredients (API) by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Biological API
  9. 2.3.3 Chemical Based API
  10. 2.3.4 Highly Potent APl(HPAPI)
  11. 2.4 Veterinary Active Pharmaceutical Ingredients (API) by Application
  12. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  13. 2.4.2 CDMO
  14. 2.4.3 CMO
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales (k units) of Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Active Pharmaceutical Ingredients (API) Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Veterinary Active Pharmaceutical Ingredients (API) Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Product Type & Application
  8. 3.8 Global Manufacturers of Veterinary Active Pharmaceutical Ingredients (API), Established Date
  9. 3.9 Global Veterinary Active Pharmaceutical Ingredients (API) Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd
  2. 4.1.1 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Company Information
  3. 4.1.2 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Business Overview
  4. 4.1.3 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  6. 4.1.5 Qilu Pharmaceutical (Inner Mongolia) Co, Ltd Recent Developments
  7. 4.2 Jiangsu Lingyun Pharmaceutical Co. Ltd
  8. 4.2.1 Jiangsu Lingyun Pharmaceutical Co. Ltd Company Information
  9. 4.2.2 Jiangsu Lingyun Pharmaceutical Co. Ltd Business Overview
  10. 4.2.3 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Jiangsu Lingyun Pharmaceutical Co. Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  12. 4.2.5 Jiangsu Lingyun Pharmaceutical Co. Ltd Recent Developments
  13. 4.3 SUANFARMAOfichem Group
  14. 4.3.1 SUANFARMAOfichem Group Company Information
  15. 4.3.2 SUANFARMAOfichem Group Business Overview
  16. 4.3.3 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 SUANFARMAOfichem Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  18. 4.3.5 SUANFARMAOfichem Group Recent Developments
  19. 4.4 Procyon Life Sciences
  20. 4.4.1 Procyon Life Sciences Company Information
  21. 4.4.2 Procyon Life Sciences Business Overview
  22. 4.4.3 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Procyon Life Sciences Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  24. 4.4.5 Procyon Life Sciences Recent Developments
  25. 4.5 NGL Fine-Chem Ltd
  26. 4.5.1 NGL Fine-Chem Ltd Company Information
  27. 4.5.2 NGL Fine-Chem Ltd Business Overview
  28. 4.5.3 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 NGL Fine-Chem Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  30. 4.5.5 NGL Fine-Chem Ltd Recent Developments
  31. 4.6 Menadiona
  32. 4.6.1 Menadiona Company Information
  33. 4.6.2 Menadiona Business Overview
  34. 4.6.3 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Menadiona Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  36. 4.6.5 Menadiona Recent Developments
  37. 4.7 lndukern Group
  38. 4.7.1 lndukern Group Company Information
  39. 4.7.2 lndukern Group Business Overview
  40. 4.7.3 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 lndukern Group Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  42. 4.7.5 lndukern Group Recent Developments
  43. 4.8 LasaSupergenerics Ltd.
  44. 4.8.1 LasaSupergenerics Ltd. Company Information
  45. 4.8.2 LasaSupergenerics Ltd. Business Overview
  46. 4.8.3 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 LasaSupergenerics Ltd. Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  48. 4.8.5 LasaSupergenerics Ltd. Recent Developments
  49. 4.9 Huvepharma
  50. 4.9.1 Huvepharma Company Information
  51. 4.9.2 Huvepharma Business Overview
  52. 4.9.3 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Huvepharma Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  54. 4.9.5 Huvepharma Recent Developments
  55. 4.10 Excel Veterinary HealthcareVetpharma(Insud Pharma)
  56. 4.10.1 Excel Veterinary HealthcareVetpharma(Insud Pharma) Company Information
  57. 4.10.2 Excel Veterinary HealthcareVetpharma(Insud Pharma) Business Overview
  58. 4.10.3 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Excel Veterinary HealthcareVetpharma(Insud Pharma) Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  60. 4.10.5 Excel Veterinary HealthcareVetpharma(Insud Pharma) Recent Developments
  61. 4.11 Alivira Animal Health Ltd
  62. 4.11.1 Alivira Animal Health Ltd Company Information
  63. 4.11.2 Alivira Animal Health Ltd Business Overview
  64. 4.11.3 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Alivira Animal Health Ltd Veterinary Active Pharmaceutical Ingredients (API) Product Portfolio
  66. 4.11.5 Alivira Animal Health Ltd Recent Developments
5 Global Veterinary Active Pharmaceutical Ingredients (API) Market Scenario by Region
  1. 5.1 Global Veterinary Active Pharmaceutical Ingredients (API) Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021-2032
  3. 5.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2021-2026
  4. 5.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Region: 2027-2032
  5. 5.3 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2021-2032
  6. 5.3.1 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2021-2026
  7. 5.3.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Region: 2027-2032
  8. 5.4 North America Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
  9. 5.4.1 North America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  11. 5.4.3 North America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
  16. 5.5.1 Europe Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  18. 5.5.3 Europe Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
  41. 5.7.1 South America Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  43. 5.7.3 South America Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.7.7 Colombia
  48. 5.8 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Market Facts & Figures by Country
  49. 5.8.1 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Market Size by Country: 2021 VS 2025 VS 2032
  50. 5.8.2 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Sales by Country (2021-2032)
  51. 5.8.3 Middle East and Africa Veterinary Active Pharmaceutical Ingredients (API) Revenue by Country (2021-2032)
  52. 5.8.4 Egypt
  53. 5.8.5 South Africa
  54. 5.8.6 Israel
  55. 5.8.7 Türkiye
  56. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032)
  2. 6.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032) & (k units)
  3. 6.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Type (2021-2032)
  4. 6.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Type (2021-2032)
  5. 6.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032)
  2. 7.1.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032) & (k units)
  3. 7.1.2 Global Veterinary Active Pharmaceutical Ingredients (API) Sales Market Share by Application (2021-2032)
  4. 7.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue by Application (2021-2032)
  5. 7.2.1 Global Veterinary Active Pharmaceutical Ingredients (API) Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Veterinary Active Pharmaceutical Ingredients (API) Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Veterinary Active Pharmaceutical Ingredients (API) Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Veterinary Active Pharmaceutical Ingredients (API) Value Chain Analysis
  2. 8.1.1 Veterinary Active Pharmaceutical Ingredients (API) Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Veterinary Active Pharmaceutical Ingredients (API) Production Mode & Process
  5. 8.2 Veterinary Active Pharmaceutical Ingredients (API) Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Veterinary Active Pharmaceutical Ingredients (API) Distributors
  8. 8.2.3 Veterinary Active Pharmaceutical Ingredients (API) Customers
9 Global Veterinary Active Pharmaceutical Ingredients (API) Analyzing Market Dynamics
  1. 9.1 Veterinary Active Pharmaceutical Ingredients (API) Industry Trends
  2. 9.2 Veterinary Active Pharmaceutical Ingredients (API) Industry Drivers
  3. 9.3 Veterinary Active Pharmaceutical Ingredients (API) Industry Opportunities and Challenges
  4. 9.4 Veterinary Active Pharmaceutical Ingredients (API) Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst